Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.
"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.
“Colorado as a state was supposed to be a safe haven,” said one mother, as families now scramble to maintain gender-affirming care amid legal uncertainty.
New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
EGRIFTA WR™ has received FDA approval for use in adults with HIV and lipodystrophy to reduce excess abdominal fat with once-weekly reconstitution and a lower injection volume.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.
Researchers found "no increased risk of invasive cervical cancer or high-grade cervical intraepithelial neoplasia in transmasculine and gender-diverse (TMGD) [individuals] using gender-affirming hormone therapy," but added that the findings should be interpreted with caution.
In a first-of-its-kind RCT, early testosterone access led to an 11.6-point improvement in self-rated health scores among transgender and gender-diverse adults, while delayed-treatment controls showed no significant change.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.